Published in Psychiatry Res on June 02, 2008
Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology (2010) 1.62
Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety (2010) 1.47
Evidence-Based Assessment of Obsessive-Compulsive Disorder. J Cent Nerv Syst Dis (2016) 1.40
Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder. Biol Psychiatry (2013) 1.27
Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology (2012) 1.17
Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet (2010) 1.10
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology (2013) 1.08
A 2-year prospective follow-up study of the course of obsessive-compulsive disorder. J Clin Psychiatry (2010) 1.04
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology (2012) 1.04
Sexual orientation obsessions in obsessive-compulsive disorder: prevalence and correlates. Psychiatry Res (2010) 0.98
Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med (2008) 0.97
The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci (2010) 0.95
Myth of the pure obsessional type in obsessive--compulsive disorder. Depress Anxiety (2011) 0.92
Five-year course of obsessive-compulsive disorder: predictors of remission and relapse. J Clin Psychiatry (2013) 0.92
Homosexual Obsessive Compulsive Disorder (HOCD): A Rare Case Report. J Clin Diagn Res (2015) 0.91
Genetics of obsessive-compulsive disorder. Psychiatr Clin North Am (2010) 0.90
Capacity to delay reward differentiates obsessive-compulsive disorder and obsessive-compulsive personality disorder. Biol Psychiatry (2013) 0.90
Juvenile-onset OCD: clinical features in children, adolescents and adults. Acta Psychiatr Scand (2008) 0.88
Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder. J Psychiatry Neurosci (2012) 0.85
Error-related negativity in individuals with obsessive-compulsive symptoms: toward an understanding of hoarding behaviors. Biol Psychol (2012) 0.83
The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. J Anxiety Disord (2014) 0.82
In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept. Psychiatry Res (2015) 0.82
Symptom dimensions in obsessive-compulsive disorder: phenomenology and treatment outcomes with exposure and ritual prevention. Psychopathology (2013) 0.82
Homeobox genes in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 0.81
Symptom Dimensions in Two Samples of Africans Americans with Obsessive-Compulsive Disorder. J Obsessive Compuls Relat Disord (2012) 0.80
Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907. Biol Psychiatry (2011) 0.80
Assessing neurocognitive function in psychiatric disorders: a roadmap for enhancing consensus. Neurobiol Learn Mem (2014) 0.79
Reward-based spatial learning in unmedicated adults with obsessive-compulsive disorder. Am J Psychiatry (2014) 0.79
Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? J Consult Clin Psychol (2015) 0.79
Symmetry Concerns as a Symptom of Body Dysmorphic Disorder. J Obsessive Compuls Relat Disord (2013) 0.78
Obsessive compulsive symptom dimensions and neuroticism: An examination of shared genetic and environmental risk. Am J Med Genet B Neuropsychiatr Genet (2014) 0.77
A Study of the Prevalence of Psychiatric Disorders in Patients with Methamphetamine-Induced Psychosis. Addict Health (2015) 0.76
Assessing Sexually Intrusive Thoughts: Parsing Unacceptable Thoughts on the Dimensional Obsessive-Compulsive Scale. Behav Ther (2015) 0.76
Treatment of Sexual-Orientation Obsessions in Obsessive-Compulsive Disorder Using Exposure and Ritual Prevention. Clin Case Stud (2011) 0.75
Prevalence of Childhood Obsessive-Compulsive Personality Traits in Adults with Obsessive Compulsive Disorder versus Obsessive Compulsive Personality Disorder. J Obsessive Compuls Relat Disord (2015) 0.75
Distinguishing Fear Versus Distress Symptomatology in Pediatric OCD. Child Psychiatry Hum Dev (2017) 0.75
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry (1970) 8.51
A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry (2005) 2.75
Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry (2004) 2.40
A family study of obsessive-compulsive disorder. Am J Psychiatry (1995) 2.24
Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry (1992) 2.21
Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. J Psychiatr Res (1986) 2.11
Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand (2004) 2.05
A family study of obsessive-compulsive disorder. Arch Gen Psychiatry (2000) 2.03
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry (1999) 2.03
Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 2.00
Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom (2002) 1.94
Symptoms of obsessive-compulsive disorder. Am J Psychiatry (1997) 1.88
Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther (2002) 1.63
Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry (1994) 1.59
The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry (2006) 1.57
The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry (2006) 1.53
Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry (2005) 1.44
Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry (2002) 1.39
Taboo thoughts and doubt/checking: a refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Res (2007) 1.36
A factor analysis of the signs and symptoms of mania. Arch Gen Psychiatry (1998) 1.30
Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biol Psychiatry (2006) 1.29
Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry (2001) 1.26
Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry (2006) 1.22
Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet (2003) 1.21
Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther (1999) 1.18
Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry (1998) 1.16
Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet (2002) 1.13
Obsessive-compulsive disorder subtypes: an attempted replication and extension of a symptom-based taxonomy. Behav Res Ther (2004) 1.09
The OCD collaborative genetics study: methods and sample description. Am J Med Genet B Neuropsychiatr Genet (2006) 1.08
Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet (1999) 1.05
[Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients]. Encephale (1996) 1.04
Familiality of symptom dimensions in depression. Arch Gen Psychiatry (2004) 1.00
Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res (2004) 0.98
Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci (2003) 0.98
Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder?--Findings from an Indian study. Eur Child Adolesc Psychiatry (2003) 0.97
Obsessive-compulsive disorder subgroups: a symptom-based clustering approach. Behav Res Ther (1999) 0.95
The structure of childhood obsessions and compulsions: dimensions in an outpatient sample. Behav Res Ther (2006) 0.93
Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder. Depress Anxiety (2007) 0.91
Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol Bull (1988) 0.90
Symptom patterns in children and adolescents with obsessive-compulsive disorder (OCD). Behav Res Ther (2005) 0.78
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA (2009) 12.35
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med (2008) 10.48
Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20
Genomewide association study of leprosy. N Engl J Med (2009) 8.17
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Mapping human genetic diversity in Asia. Science (2009) 7.40
In vivo genome editing using a high-efficiency TALEN system. Nature (2012) 7.11
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry (2003) 6.93
Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 6.79
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry (2003) 6.52
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry (2007) 5.56
Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet (2008) 5.04
Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry (2009) 4.84
Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med (2012) 4.68
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A (2009) 4.25
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis (2002) 4.23
Meditation experience is associated with increased cortical thickness. Neuroreport (2005) 4.15
A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry (2005) 4.07
Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med (2003) 3.99
Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 3.96
Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci (2006) 3.78
The SOL Genomics Network: a comparative resource for Solanaceae biology and beyond. Plant Physiol (2005) 3.65
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry (2004) 3.64
Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry (2008) 3.63
Ascertainment adjustment in complex diseases. Genet Epidemiol (2002) 3.63
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol (2003) 3.54
Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke (2004) 3.53
Genome characteristics of facultatively symbiotic Frankia sp. strains reflect host range and host plant biogeography. Genome Res (2006) 3.53
Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn Mem (2006) 3.52
The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord (2005) 3.51
Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement. Nat Biotechnol (2013) 3.41
Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci U S A (2004) 3.40
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry (2009) 3.32
Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol (2006) 3.32
A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One (2008) 3.25
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry (2009) 3.17
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell (2005) 3.15
Human anterior cingulate neurons and the integration of monetary reward with motor responses. Nat Neurosci (2004) 3.05
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry (2002) 2.99
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94
L-histidine decarboxylase and Tourette's syndrome. N Engl J Med (2010) 2.92
Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty. Science (2003) 2.91
Reducing deep sedation and delirium in acute lung injury patients: a quality improvement project. Crit Care Med (2013) 2.89
Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry (2008) 2.86
Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry (2007) 2.84
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation. Blood (2009) 2.82
Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. Gen Hosp Psychiatry (2008) 2.81
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 2.80
Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci U S A (2005) 2.78
Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res (2008) 2.78
A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry (2007) 2.78
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry (2002) 2.70
Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. J Am Acad Child Adolesc Psychiatry (2012) 2.69
Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A (2008) 2.65
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 2.63
The burden of mental disorders. Epidemiol Rev (2008) 2.62
Clinical characteristics of anxiety disordered youth. J Anxiety Disord (2010) 2.59
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology (2006) 2.58
Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57
Experimental evidence for epitaxial silicene on diboride thin films. Phys Rev Lett (2012) 2.56
Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet (2003) 2.55